Iwahashi Kazuhiko, Nishizawa Daisuke, Narita Shin, Numajiri Maki, Murayama Ohoshi, Yoshihara Eiji, Onozawa Yuuya, Nagahori Kenta, Fukamauchi Fumihiko, Ikeda Kazutaka, Ishigooka Jun
*Laboratory of Physiology, Psychophysiology/Psychiatry Project, the Graduate School of Environmental Health, and †Health Administration Center, Azabu University, Sagamihara; ‡Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science; §Department of Neuropsychiatry, Tokyo Women's Medical University, Tokyo; ∥Laboratory of Molecular Biology, School of Life and Environmental Science, Azabu University, Sagamihara; and ¶Enomoto Clinic, Tokyo, Japan.
Clin Neuropharmacol. 2014 Jul-Aug;37(4):108-10. doi: 10.1097/WNF.0000000000000039.
The GSK-3β gene, GSK3B, codes for an enzyme that is a target for the action of mood stabilizers, lithium and possibly valproic acid.In this study, the relationship between haplotypes consisting of single nucleotide polymorphisms (SNPs) of GSK3B -50T/C and -1727A/T and the effect of lithium was studied among Japanese bipolar disorder lithium nonresponders and responders.The distributions of the GSK3B haplotypes (-50T/C and -1727A/T) showed a trend for significant difference between the lithium nonresponders and responders (global P=0.07074). Haplotype 1 (T-A) was associated with a higher lithium response (haplotype-specific P=0.03477), whereas haplotype 2 (C-A) was associated with a lower lithium response (haplotype-specific P=0.03443).The pairwise D' and r values between the 2 SNPs in this study were 1.0 and 0.097, respectively. The 2 SNPs showed weak linkage disequilibrium with each other.
GSK-3β基因(GSK3B)编码一种酶,该酶是心境稳定剂锂盐以及可能还有丙戊酸作用的靶点。在本研究中,我们在日本双相情感障碍锂盐治疗无反应者和有反应者中,研究了由GSK3B -50T/C和-1727A/T单核苷酸多态性(SNP)组成的单倍型与锂盐疗效之间的关系。GSK3B单倍型(-50T/C和-1727A/T)的分布在锂盐治疗无反应者和有反应者之间显示出显著差异的趋势(总体P = 0.07074)。单倍型1(T-A)与较高的锂盐反应相关(单倍型特异性P = 0.03477),而单倍型2(C-A)与较低的锂盐反应相关(单倍型特异性P = 0.03443)。本研究中这两个SNP之间的成对D'和r值分别为1.0和0.097。这两个SNP彼此显示出弱连锁不平衡。